Clinical depression and inflammatory risk markers for coronary heart disease

American Journal of Cardiology

Volumn 90, Issue 12, 2002, Pages 1279-1283

  Miller, Gregory E ^a,b,c   Stetler, Cinnamon A ^a,b,c   Carney, Robert M ^a,b,c   Freedland, Kenneth E ^a,b,c   Banks, William A ^a,b,c  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; ORAL CONTRACEPTIVE AGENT;

ADULT; AFRICA; ANAMNESIS; ARTICLE; BODY MASS; CAUCASIAN; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; DEMOGRAPHY; DEPRESSION; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FEMALE; HUMAN; INFECTION; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RACE; RISK ASSESSMENT; VIRUS INFECTION;

ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; OBESITY; ODDS RATIO; RISK FACTORS; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037114792     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)02863-1     Document Type: Article

References (30)

1. Barefoot J.C., Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation. 93:1996;1976-1980.
2. Anda R.F., Williamson D., Jones D. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology. 4:1993;285-294.
3. Carney R.M., Rich M.W., Freedland K.E., teVelde A.J., Saini J., Simeone C., Clark K. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med. 50:1988;627-633.
4. Frasure-Smith N., Lesperance F., Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA. 270:1993;1819-1825.
5. Glassman A.H., Shapiro P.A. Depression and the course of coronary artery disease. Am J Psychiatry. 155:1998;4-11.
6. Musselman D.L., Evans D.L., Nemeroff C.B. The relationship of depression to cardiovascular disease. Arch Gen Psychiatry. 55:1998;580-592.
7. Carney R.M., Freedland K.E., Miller G.E., Jaffe A.S. Depression as a risk factor for cardiac mortality and morbidity a review of potential mechanisms . J Psychosom Res. 53:2002;897-902.
8. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 340:1999;115-126.
9. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 104:2001;365-372.
10. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 342:2000;836-843.
11. Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 101:2000;1767-1772.
12. Danesh J., Collins R., Appleby P., Peto R. Fibrinogen, C-reactive protein, albumin, and white cell count meta-analyses of prospective studies of coronary heart disease . JAMA. 279:2000;1477-1482.
13. Yudkin J.S., Kumari M., Humphries S.E., Mohamed-Ali V. Inflammation, obesity, stress, and coronary heart disease is interleukin-6 the link? Atherosclerosis. 148:2001;209-214.
14. Libby P., Egan D., Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis an assessment of the evidence and need for future research . Circulation. 96:1997;4095-4103.
15. Diagnostic and Statistical Manual of Mental Disorders. 1994;APA, Washington, DC. 327.
16. Freedland K.E., Skala J.A., Carney R.M., Raczynski J.M., Taylor C.B., Mendes de Leon C.F., Ironson G., Youngblood M.E., Krishnan K.R.R., Veith R.C. The Depression Interview and Structured Hamilton (DISH) rationale, development, characteristics, and clinical validity . Psychosom Med. 2002;. in press.
17. Robins L.N., Helzer J.E., Croughan J., Ratcliff K. The NIMH diagnostic interview schedule its history, characteristics, and validity . Arch Gen Psychiatry. 38:1981;381-389.
18. Spitzer R.L., Williams J.B.W., Kroenke K., Linzer M., deGruy F.V., Hahn S.R., Brody D., Johnson J.G. Utility of a new procedure for diagnosing mental disorders in primary care the PRIME-MD 1000 study . JAMA. 272:1994;1749-1756.
19. Baron R.M., Kenny D.A. The mediator-moderator variable distinction in social psychological research conceptual, statistical, and strategical considerations . J Pers Soc Psychol. 51:1985;1173-1182.
20. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 336:1997;973-979.
21. Kop W.J., Gottdiener J.S., Tangen C.M., Fried L.P., McBurnie M.A., Walston J., Newman A.B., Hirsch C., Tracy R.P. Inflammatory and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol. 89:2002;419-424.
22. Dentino A.N., Pieper C.F., Rao K.M.K., Currie M.S., Harris T., Blazer D.G., Cohen H.J. Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatric Soc. 47:1999;6-11.
23. Lutgendorf S.K., Garand L., Buckwalter K.C., Reimer T.T., Hong S.Y., Lubaroff D.M. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J Gerontol Biol Sci Med Sci. 54:1999;M434-M439.
24. Appels A., Bar F.W., Bar J., Bruggeman C., de Baets M. Inflammation, depressive symptomatology and coronary artery disease. Psychosom Med. 62:2000;601-605.
25. Maes M., Bosmans E., De Jongh R., Kenis G., Vandoolaeghe E., Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 9:1997;853-858.
26. Thakore J.H., Richards P.J., Reznek R.H., Martin A., Dinan T.G. Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biol Psychiatry. 41:1997;1140-1142.
27. Mohamed-Ali V., Goodrick S., Katz D.R., Miles J.M., Yudkin J.S., Klein S., Coppack S.W. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α in vivo. J Clin Endocrinol Metab. 82:1997;4196-4200.
28. Papanicoloaou D.A., Wilder R.L., Manolagas S.C., Chrousos G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 128:1998;127-137.
29. Maier S.F., Watkins L.R. Cytokines for psychologists implications of bi-directional immune-to-brain communication for understanding behavior, mood, and cognition . Psychol Rev. 105:1998;83-107.
30. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus. JAMA. 286:2001;327-334.